Beijing
China
6
2022-11-24
6
2025-10-14
These are the the leading inventors for applications assigned to SinoCellTech Ltd.:
SinoCellTech Ltd. based in Beijing, CN has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Polyvalent immunogenicity composition for human papillomavirus
#2 | 2022-09-08 ✅ Patent 12,139,514 granted on 2024-11-12Chimeric papilloma virus L1 protein
#3 | 2022-05-12 ✅ Patent 12,516,113 granted on 2026-01-06Humanized anti-IL17A antibody and application thereof
#4 | 2022-05-12 ✅ Patent 12,060,416 granted on 2024-08-13Humanized anti-VEGF monoclonal antibody
#5 | 2022-05-05 ✅ Patent 12,479,911 granted on 2025-11-25Humanized anti-VEGF antibody Fab fragment and use thereof
#6 | 2022-01-06 ✅ Patent 12,275,790 granted on 2025-04-15Humanized anti-PD-1 antibody and the use thereof
Also check out SINOCELLTECH LTD's (Beijing, China) applicant profile with 18 patent applications submitted.
622057 ⎘